REQUEST A DEMO
Total
USD $0.00
Search more companies

Cyc-Urologia S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Cyc-Urologia S.A.S. Profile Updated: August 02, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Cyc-Urologia S.A.S. is based in Ecuador, with the head office in Cuenca. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on April 12, 2022. It currently has a total number of 4 (2023) employees. From the latest financial highlights, Cyc-Urologia S.A.S. reported a net sales revenue increase of 4.22% in 2023. During that time, Cyc-Urologia S.A.S.’s total assets grew by 358.75%. The net profit margin of Cyc-Urologia S.A.S. decreased by 40.39% in 2023.

Headquarters
Calle Alfonso Moreno Mora, 2-179
Cuenca; Azuay;

Contact Details: Purchase the Cyc-Urologia S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Cyc-Urologia S.A.S. report to view the information.
Outstanding Shares:
Purchase the Cyc-Urologia S.A.S. report to view the information.
Registered Capital:
Purchase the Cyc-Urologia S.A.S. report to view the information.
Incorporation Date:
April 12, 2022
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Cyc-Urologia S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
4.22%
Total operating revenue
4.22%
EBITDA
85912.97%
Net Profit (Loss) for the Period
-86.43%
Total assets
358.75%
Total equity
458.74%
Net Profit Margin
-40.39%
Return on Equity (ROE)
-101.23%
Quick Ratio
12.26%
Cash Ratio
14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?